Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s developer/version footer was updated from Revision v3.5.2 to v3.5.3, reflecting a site release rather than a study record change.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:45.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added revision: v3.5.2 and removed revision: v3.5.0 from the record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:37.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and deleted Revision: v3.4.3 in the Record History.
    Difference
    0.1%
    Check dated 2026-03-19T05:41:23.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the study record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:27:50.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The history shows a new site revision v3.4.2 added, and the government funding notice as well as the v3.4.1 revision entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T14:16:57.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with operating status guidance. Updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.8%
    Check dated 2026-02-04T10:25:18.000Z thumbnail image

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.